COQUÍ RADIOPHARMACEUTICALS - Key Persons

Job Titles:

• CEO
• Chairman of the Board of Directors
• President
• Coquí Pharma President and CEO
• Founder, CEO, President and Chairman of the Board of Directors

Mrs. Bigles brings more than 18 years of leadership experience in the design, construction, licensing, and operation of medical facilities. Her educational background in mathematics, architecture, and urban planning and her intuitive analytical and problem-solving skills, along with a deep knowledge of building construction and land development, create a baseline for excelling at managing projects at both macro and micro levels. Her medical facilities construction experience has given her critical skills that ensure compliance with applicable design and established regulations and codes. She is committed to cost efficiency and quick turnaround of projects with high-quality, low-risk approaches while delivering value to customers and shareholders alike. Her keen attention to detail and exceptional organizational skills contribute to her ability to identify and eliminate problems quickly to keep projects on track, on budget, and on schedule. Mrs. Bigles worked as Project Coordinator for Gresham, Smith and Partners. Her duties included convening meetings between the architectural firm and engineering and construction professionals for review of drawings for HVAC systems and mechanical and other engineering details, in preparation for the construction phase of primarily medical facilities. Carmen I. Bigles is President and CEO of Coquí RadioPharmaceuticals (Coquí Pharma). Prior to founding Coquí Pharma, Bigles co-founded and served as CFO of Caribbean Radiation Oncology Center in Puerto Rico. The center is one of the region's premier medical facilities for advanced oncological radiation technology. Bigles oversaw the $12 million construction of the center's first facility in Bayamon, Puerto Rico, and ensured the clinic was opened one year ahead of schedule. Bigles was born in San Juan, Puerto Rico. She earned a bachelor's degree in mathematics from Interamerican University in San Juan in 1997 and two master's degrees, the first in architecture and the second in suburban and town planning, from the University of Miami in 2000.

Job Titles:

• for Media Inquiries Contact

Job Titles:

• Professor, Medical Director, and Director of Clinical & Translational Research

James Welsh, MS, MD, FACRO, is a board-certified radiation oncologist and neuro-oncologist. Dr. Welsh obtained his master's degree in molecular biophysics and biochemistry from Yale University and his M.D. from the State University of New York at Stony Brook. He completed his residency training at The Johns Hopkins Hospital in Baltimore, Maryland and stayed on the Johns Hopkins faculty as an Assistant Professor of Oncology until 2001. Subsequently, Dr. Welsh completed a fellowship at the University of Wisconsin investigating helical TomoTherapy, a newly developed form of image-guided, intensity-modulated radiotherapy technology. He joined the faculty at the University of Wisconsin and became Clinical Professor of Human Oncology and Medical Physics. From there, Dr. Welsh served brief stints as Professor of Neurosurgery and Radiology at the Louisiana State University School of Medicine-Shreveport and as a radiation oncologist at Willis-Knighton Hospital. He then returned to the Midwest as the fast neutron therapy physician at the Northern Illinois University Institute for Neutron Therapy at Fermilab. Dr. Welsh is currently Professor, Medical Director, and Director of Clinical & Translational Research in the Department of Radiation Oncology at the Stritch School of Medicine at Loyola University-Chicago and Chief of Radiation Oncology at the Edward Hines Jr. VA Hospital. He is also Chairman of the Board for the American College of Radiation Oncology, sits on the editorial boards for several scientific and medical journals, and serves on the Advisory Committee on the Medical Uses of Isotopes, which advises the NRC on medical issues.

Gresham Smith is a comprehensive multi-disciplinary architectural, engineering, and environmental firm that will assist Coquí Pharma with site selection. Gresham Smith's primary responsibilities are to draft environmental reviews, collect site data, and prepare the Environmental Report for MIPF applications. Gresham Smith is headquartered in Nashville, Tennessee and has more than 650 employees. The firm assists private and public sector clients nationally in developing new facilities including design, permitting, and environmental reviews.

Job Titles:

• Member of the Board
• Director for the Board of First Energy Corporation

Luis Reyes has more than 35 years of nuclear experience. He served in various Nuclear Regulatory Commission (NRC) senior management positions, and the NRC consistently received the highest rating on its Government Performance Assessment review during his tenure. Reyes also served as executive-on-loan to the U.S. Department of Energy (DOE) to conduct a nuclear safety review at the DOE Assistant Secretary's request. He was an expert consultant to the International Atomic Energy Agency (IAEA) in the areas of operations experience, new nuclear plant construction, and regulatory organizations. On behalf of the IAEA, Reyes led a team of international experts in the review of a European country's regulatory organization. He is currently owner of Luis Reyes Consulting LLC. Reyes' numerous honors and awards include the Presidential Distinguished Rank award and the Presidential Meritorious Rank award, which he was awarded three times. These awards are distributed by the President of the United States to a small group of career senior executives and senior career employees. Reyes earned a Bachelor of Science in electrical engineering and a Master of Science in nuclear engineering from the University of Puerto Rico-Mayaguez. He also attended the Federal Executive Institute at the Harvard University Kennedy School of Government.

Job Titles:

• Member of the Board
• CFO for Forward Industries Inc
• CFO, Executive Vice President, and Secretary of QuePasa Corp

Michael Matte is CFO, Executive Vice President, and Secretary of QuePasa Corp. He is also a director of Iris International, Inc. and GelTech Solutions, Inc. Matte served as a director of QuePasa from July 2006 through October 2007 and as CFO of Cyberguard Corp. from February 2001 to April 2006. Prior to joining Cyberguard, Matte was a senior audit manager for Price Waterhouse from 1981 to 1992. Michael Matte is CFO for Forward Industries Inc. He has extensive experience as a CFO with public and private companies, including Aspen Group, Meet me Inc. (formerly Quepasa Corporation), Cyberguard Corporation, Amerijet International, Intime Systems International, Inc., and TORWEST, Inc. He also served as a senior audit manager for Price Waterhouse from 1981 to 1992. Matte has significant experience in rapidly growing businesses and his industry experience includes technology, software development, distribution, transportation, and medical diagnostic equipment.

Job Titles:

• Member of the Board

Pedro A. Serrano-Ojeda MD is a Board Certified Radiation Oncologist. He obtained his Bachelor in Science degree from the University of Puerto Rico, Mayaguez Campus, his MD from the Ponce School of Medicine (Puerto Rico) and his Radiation Oncology specialty from the Medical College of Wisconsin Affiliated Hospitals and Clinics (Milwaukee). He was mentored by Dr. Frank Wilson, the prodigy student of Dr. Juan de Regatos, founder of Radiation Oncology in the United States, who in turn trained under Marie Currie. This lineage has marked Dr. Serrano; it has given him the impetus to not only treat cancer, but more so, to find a cure. He has been in the private practice since 1999 and currently is the president and owner of Caribbean Radiation Oncology Center. (CROC). www.adioscancer.com Dr. Pedro Serrano-Ojeda, M.D., is a certified radiation oncologist who founded Caribbean Radiation Oncology Center in Puerto Rico in 2007. He expanded the company in 2015, opening a second location in Doral, Florida. The facility is one of the first in Florida to feature the TomoTherapy HAD unit - the latest TomoTherapy Hi-Art Treatment System and the most integrated and advanced system for comprehensive cancer treatment that is available today. Dr. Serrano-Ojeda received his medical degree from the Ponce School of Medicine & Health Sciences. During his residency at the Medical College of Wisconsin, he studied under the guidance of prominent medical professionals such as Dr. Frank Wilson, the protégé of the legendary radiation oncologist Dr. Juan Del Regato. In 2009, quality control data for Caribbean Radiation Oncology Center's first 264 patients was published in the journal, Medical Physics. It was the largest study at the time. Dr. Serrano-Ojeda has spoken at conferences throughout the U.S. and Latin America on behalf of TomoTherapy and Accuray, the manufacturer of the TomoTherapy technology, to teach techniques and offer insight on his experience with the machines.

Job Titles:

• PYA Chief Alliance Officer

PYA Chief Alliance Officer Tom Ballard profiled Carmen Bigles for Teknovation.biz, outlining Coqui's mission and plans to build the nation's first facility to produce medical radioisotopes in Oak Ridge, Tennessee.